Rasagiline in Subjects With Amyotrophic Lateral Sclerosis (ALS)

Condition:   Amyotrophic Lateral Sclerosis (ALS)
Interventions:   Drug: Rasagiline;   Drug: Placebo
Sponsors:   Richard Barohn, MD;   FDA Office of Orphan Products Development
Active, not recruiting - verified January 2017